Potassium Intake in Patients With Chronic Kidney Disease
NCT00949585 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2012-09-19
Summary
Chronic kidney disease is associated with high blood pressure, heart disease, and strokes. Potassium lowers blood pressure and may help prevent heart disease and strokes in the general population, but has not been well-studied in people with kidney disease. This study will look at the benefits and safety of two levels of potassium intake in patients with kidney disease. We expect that a higher level of potassium intake safely lowers blood pressure compared to a lower level of potassium intake. We hope that this and other research projects will help us to learn more so that guidelines can be created for potassium intake in patients with chronic kidney disease
Conditions
Interventions
- OTHER
-
Dietary intake of potassium
Comparison of two diets: one contains 100 mmol potassium per day, and the other contains 40 mmol potassium per day
Sponsors & Collaborators
- collaborator OTHER
- lead OTHER
Principal Investigators
-
Sharon Turban, MD, MHS · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- United States
Study Locations
More Related Trials
-
Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial
NCT00974636 ·Status: COMPLETED ·Phase: NA
-
Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study
NCT04466969 ·Status: COMPLETED
-
Ketone Ester And Salt (KEAS) in Older Adults
NCT06868719 ·Status: RECRUITING ·Phase: NA
-
Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I
NCT00004328 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)
NCT04968184 ·Status: TERMINATED ·Phase: PHASE3
-
Sodium-Endothelial Function-CKD Study
NCT00141622 ·Status: COMPLETED ·Phase: NA
-
Pre-ESRD Syndrome in High Risk African Americans
NCT00224939 ·Status: TERMINATED ·Phase: NA
-
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS
NCT07178964 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD
NCT04192110 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment
NCT02653014 ·Status: COMPLETED ·Phase: PHASE1
-
Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide
NCT00356265 ·Status: TERMINATED ·Phase: NA
-
Diuretics, Hypertension, and Arrhythmias Clinical Trial
NCT00000525 ·Status: COMPLETED ·Phase: PHASE3
-
Chronotherapy in Children With Chronic Kidney Disease
NCT05353335 ·Status: WITHDRAWN ·Phase: NA
-
The Role of Mineralocorticoid Receptors in Vascular Function
NCT00759525 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
NCT04162366 ·Status: WITHDRAWN ·Phase: PHASE3
-
Examination of Potassium Levels in Saliva in ESRD Patients
NCT02596386 ·Status: UNKNOWN
-
Hyperkalaemia Prevalence, Recurrence and Treatment in Haemodialysis
NCT04799067 ·Status: COMPLETED
-
Mechanisms and Treatment of Intradialytic Hypertension
NCT00827775 ·Status: COMPLETED ·Phase: PHASE4
-
Steroids on Intra-dialytic Hypotension
NCT03465007 ·Status: COMPLETED ·Phase: NA
-
Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes
NCT06545461 ·Status: COMPLETED ·Phase: NA
-
Dietary Acid Reduction and Progression of Chronic Kidney Disease
NCT06046924 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD
NCT01750294 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease
NCT03574363 ·Status: COMPLETED ·Phase: PHASE2
-
Haemodialysis Salt Reduction Study
NCT00141609 ·Status: COMPLETED ·Phase: NA
-
Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
NCT00405548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2